Relation of Serum Parathyroid Hormone to Cognitive Function in Elderly Females

  • S. Morimoto
  • F. Masugi
  • T. Hironaka
  • T. Shiraishi
  • K. Itoh
  • H. Yamamoto
  • E. Koh
  • T. Onishi
  • T. Ogihara
  • Y. Kumahara

Abstract

Senile dementia is one of the serious diseases of the aged. The cause(s) of this disease is unknown, but the role of calcium (Ca) in regulation of the mental state of elderly subjects is receiving increasing attention.1 Chronic nutritional deficiency of Ca has been suggested to induce aberrations in mineral metabolism resulting in the abnormal accumulation of Ca and non-essential trace metals in neurons.2 Possible associations of the well-known Ca-regulating hormones parathyroid hormone (PTH),3–7 calcitonin (CT)8,9 and 1,25-dihydroxyvitamin D [1,25-(0H)2D]10,11 with senile dementia have been reported. However, there have been few precise measurements of Ca and Ca-regulating hormones in elderly subjects with senile dementia. In this study, we measured Ca-related factors in elderly females with and without dementia. Cases of dementia were classified into Alzheimer- and vascular-types on the bases of cognitive function and ischemic score. We found that the circulating level of PTH was significantly elevated in cases of dementia especially of the Alzheimer-type.

Keywords

HPLC Creatinine Dementia Choline Acetyl 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. Fujita, Aging and calcium, Miner. Electrolyte Metab. 12:149 (1986).PubMedGoogle Scholar
  2. 2.
    Y. Yase, Calcium, metals and nervous system in the elderly, Nutr.Sci. Vitaminol. 31:S37 (1985).Google Scholar
  3. 3.
    J. Luxenberg, L. Z. Feigenbaum, and J. M. Aron, Reversible long standing dementia with normocalcemic hyperparathyroidism, J. Am. Geriatr. Soc. 32:546 (1984).Google Scholar
  4. 4.
    J. D. Cooper, V. C. Lazarowitz, and A. I. Arieff, Neurodiagnostic abnormalities in patients with acute renal failure, J. Clin. Invest. 61:1448 (1978).Google Scholar
  5. 5.
    D. A. Goldstein, E. I. Feinstein, L. A. Chui, R. Pattabhiraman, and S. G. Massry, The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients, Clin. Endocrinol. Metab. 51:130 (1980).Google Scholar
  6. 6.
    M. G. Cogan, C. M. Covey, A. I. Arieff, A. Wisniewski, and O. H. Clark, Central nervous system manifestations of hyperparathyroidism, Am. Med. 65:963 (1978).Google Scholar
  7. 7.
    R. Guisado, A. I. Arieff, and S. G. Massry, Changes in the electro-encephalogram in acute uremia, J. Clin. Invest. 55:738 (1975).Google Scholar
  8. 8.
    L. Robert, D. Brechemier, G. Godeau, M. L. Labat, G. Milhaud, Prevention of experimental immunarteriosclerosis by calcitonin, Biochem. Pharmacol. 26: 2129 (1977).Google Scholar
  9. 9.
    F. Insinna, P. Sarcone, Clinical research on effects of calcitonin in the treatment of chronic cerebral and peripheral obliterans arteriopathies, Int. Angiol. 4: 39 (1985).Google Scholar
  10. 10.
    W. E. Stumpf, M. Sar, S. A. Clark, Brain target sites for 1,25-dihydroxyvitamin D3, Science 215: 1403 (1982)PubMedCrossRefGoogle Scholar
  11. 11.
    J. Sonnenberg, V. N. Luine, L. C. Krey, S. Christakos, 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei, Endocrinology 118: 1433 (1986).PubMedCrossRefGoogle Scholar
  12. 12.
    K. Hasegawa, Dementia screening scale, in “Score Book of Geriatric Assessment,” L. Israel, D. Kozarevic, N. Sartrius, S Kager, Basel (1984).Google Scholar
  13. 13.
    W. G. Rosen, R. D. Terry, P. A. Fuld, R. Katzman, A. Peck, Pathological verification of ischemic score in differentiation of dementias, Ann. Neurol. 7: 486 (1980).PubMedCrossRefGoogle Scholar
  14. 14.
    R. B. Payne, A. J. Little, R. B. William, J. R. Milner, Interpretation of calcium in patients with abnormal serum protein, Br. Med. 4: 643 (1973).CrossRefGoogle Scholar
  15. 15.
    S. Morimoto, M. Tsuji, Y. Okada, T. Onishi, Y. Kumahara, The effect of oestrogen on human calcitonin secretion after calcium infusion in elderly female subjects, Clin. Endocrinol. 13: 135 (1980).Google Scholar
  16. 16.
    Y. Shimotsuji, Y. Seino, Competitive protein binding assay for 25- hydroxycholecalciferol. Methods Enzymol. 67: 466 (1980).PubMedCrossRefGoogle Scholar
  17. 17.
    Y. Seino, T. Shimotsuji, K. Yamaoka, M. Ishida, T. Ishii, S. Matsuda, C. Ikehara, H. Yabuuchi, S. Dokoh, Plasma 1,25-dihydroxyvitamin D concentrations in cords, newborns, infants and children. Calcif. Tissue Int. 30: 1 (1980).CrossRefGoogle Scholar
  18. 18.
    D. Shore, M. R. Wills, J. Savory, R. J. Wyat, Serum parathyroid hormone concentrations in senile dementia, J. Gerontol. 35: 656 (1980).PubMedGoogle Scholar
  19. 19.
    P. Davis, A. J. F. Malony, Selective loss of central cholinergic neurons in Alzheimer’s disease, Lancet 2: 1403 (1976).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • S. Morimoto
    • 1
  • F. Masugi
    • 1
  • T. Hironaka
    • 1
  • T. Shiraishi
    • 1
  • K. Itoh
    • 1
  • H. Yamamoto
    • 1
  • E. Koh
    • 1
  • T. Onishi
    • 1
  • T. Ogihara
    • 1
  • Y. Kumahara
    • 1
  1. 1.Department of Medicine and GeriatricsOsaka University Medical SchoolOsakaJapan

Personalised recommendations